Voyager Therapeutics (VYGR) Tops Q4 EPS by 5c

Voyager Therapeutics (NASDAQ: VYGR) reported Q4 EPS of ($0.46), $0.05 better than the analyst estimate of ($0.51). Revenue for the quarter came in at $15.34 million versus the consensus estimate of $9.19 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
• Gap to Introduce New Line of Handbags From Former Coach Designer - WSJ
• Rezolve Ai posts $130.8M in H1 revenue, net loss widens to $139.5M